Description
Cervical Health: Know, Prevent, Empower" emphasizes awareness and proactive measures for women's well-being. Regular cervical screenings, such as Pap smears and HPV tests, are vital for early detection of abnormalities. Understanding risk factors, including HPV infection, aids in preventive measures for cervical health. Vaccination against HPV is a powerful tool in the prevention of cervical cancer, empowering individuals to safeguard their health. Education about safe practices and the importance of regular check-ups contributes to overall cervical health. Encouraging open communication with healthcare providers ensures timely intervention and personalized care. Empowerment comes through knowledge; being informed about cervical health enables women to make informed choices. Early detection through screenings allows for more effective and less invasive treatment options. Support networks and community awareness play crucial roles in fostering a culture of cervical health.
Résumé
- Cervical cancer is the fourth most common cancer in women globally, with the highest rates in low and middle-income countries due to limited resources, vaccination, and screening. In India, it is the second leading cause of cancer deaths among women, accounting for 25% of global deaths. Cervical cancer develops in the cervix, the lower part of the uterus.
- Human papillomavirus (HPV) is the primary cause of cervical cancer. While many HPV infections are asymptomatic and self-limiting, persistent infections can lead to abnormal cell changes and eventually cancer. HPV 16 and 18 are responsible for over 80% of cervical cancers. Besides cervical cancer, HPV can also cause vaginal, vulvar, penile, oral, and anal cancers.
- Risk factors for HPV infection include unsafe sex practices, multiple sexual partners, and other STDs like HIV. Low immunity and smoking can also increase the risk. HPV vaccines, such as Saric, Gardasil 4, Gardasil 9, and CERVAVAC, offer protection against HPV infection.
- Vaccines are recommended for individuals aged 9-26, with Gardasil 9 approved for up to 45 years. Two doses are sufficient for those under 15, while three doses are required for those over 15. CERVAVAC, an Indian vaccine, is planned to be included in the National Immunization Program.
- Screening tests, including Pap smears and HPV testing, help detect abnormal cells early. Screening is recommended for women aged 30-65, with HPV tests every five years and Pap tests every three years. Abnormal results may warrant further testing or procedures like LEEP or conization.
- Symptoms of cervical cancer include abnormal vaginal bleeding, unusual discharge, and pain during intercourse. Treatment options depend on the stage of the cancer and may include surgery, chemotherapy, and radiation. The World Health Organization (WHO) aims to eliminate cervical cancer by 2030 with a strategy targeting vaccination, screening, and treatment.
Exemple de certificat
À propos des intervenants
Dr Nadia Mateen
Radio-oncologue consultant, hôpitaux Yashodha
Commentaires
Commentaires
Vous devez être connecté pour laisser un commentaire.